Prednisolone salt formulations
US8637076B2 · kind B2 · utility
2Cited by
22References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2006 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Jun 11, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2081
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to tablets containing prednisolone salts and in particular prednisolone sodium phosphates. The dosage forms include ODTs and non-ODTs, effervescent tablets and noneffervescent tablets and tablets meeting certain performance criteria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.